Cargando…

Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancer

It has been proposed that the selective elimination of cancer stem cells (CSCs) using targeted therapy could greatly reduce tumor growth, recurrence, and metastasis. To develop effective therapeutic targets for CSC elimination, we aimed to define the properties of CSC mitochondria, and identify CSC-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, In-Sung, Jeong, Yu Jeong, Han, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911179/ https://www.ncbi.nlm.nih.gov/pubmed/26350748 http://dx.doi.org/10.5483/BMBRep.2015.48.10.179

Ejemplares similares

Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells
por: Hu, Xiaoqing, et al.
Publicado: (2016)

LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application
por: Li, Xiaohua, et al.
Publicado: (2022)

Lymphoma stem cells: A step toward a new therapeutic target
por: Kim, Seok Jin
Publicado: (2011)

Two cancer stem cell‐targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model
por: Caras, Ingrid W.
Publicado: (2020)

The Impact of the “Yogic Lifestyle” on Cancer Prognosis and Survival: Can we Target Cancer Stem Cells with Yoga?
por: Beri, Kavita
Publicado: (2017)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

FBXO45 is a potential therapeutic target for cancer therapy
por: Lin, Min, et al.
Publicado: (2020)

Therapeutic potential of stem cells in orthopedics
por: Bahney, Chelsea Shields, et al.
Publicado: (2012)

The role of mitochondrial proteases in leukemic cells and leukemic stem cells
por: Mirali, Sara, et al.
Publicado: (2020)

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
por: Rovida, Elisabetta, et al.
Publicado: (2014)

miR-124, a potential therapeutic target in colorectal cancer
por: Qin, Zhen, et al.
Publicado: (2019)

The sulfiredoxin-peroxiredoxin redox system regulates the stemness and survival of colon cancer stem cells
por: Song, In-Sung, et al.
Publicado: (2021)

Regulation of neural stem cell fate decisions by mitochondrial dynamics
por: Laaper, Matthew, et al.
Publicado: (2018)

Monitoring cancer stem cells: insights into clinical oncology
por: Lin, ShuChen, et al.
Publicado: (2016)

Mitochondrial DNA Mutations in Cancer
por: Zanssen, Stefanie, et al.
Publicado: (2005)

Cancer stem cells as ‘units of selection’
por: Greaves, Mel
Publicado: (2013)

Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
por: Wang, Wenyu, et al.
Publicado: (2022)

Cancer Stem Cell Metabolism and Potential Therapeutic Targets
por: Snyder, Vusala, et al.
Publicado: (2018)

Targeting cancer stem cells via integrin β4
por: Dobson, Hannah E., et al.
Publicado: (2021)

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance
por: Harada, Kazuto, et al.
Publicado: (2018)

Stem Cells and Metastatic Cancer: Fatal Attraction?
por: Fodde, Riccardo
Publicado: (2006)

Skin Stem Cells in Silence, Action, and Cancer
por: Fuchs, Elaine
Publicado: (2018)

Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy
por: Tu, Shi-Ming, et al.
Publicado: (2023)

Regulatory issues in stem cell therapeutics in Korea: efficacy or efficiency?
por: Oh, Il-Hoan
Publicado: (2012)

Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
por: Su, Siyu, et al.
Publicado: (2022)

Right on TARGET: glutamine metabolism in cancer
por: Ratnikov, Boris, et al.
Publicado: (2015)

Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to metabolic switch during reprogramming
por: Kwon, Ok-Seon, et al.
Publicado: (2017)

The origin-of-cell harboring cancer-driving mutations in human glioblastoma
por: Lee, Joo Ho, et al.
Publicado: (2018)

Metabolic checkpoints in neurodegenerative T helper 17 (T(H)17) and neuroregenerative regulatory T (T(reg)) cells as new therapeutic targets for multiple sclerosis
por: Shen, Hongxing, et al.
Publicado: (2019)

Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care
por: Tu, Shi-Ming, et al.
Publicado: (2022)

Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
por: Tu, Shi-Ming, et al.
Publicado: (2023)

Engineering mesenchymal stromal/stem cell-derived extracellular vesicles with improved targeting and therapeutic efficiency for the treatment of central nervous system disorders
por: Iavorovschi, Alexandra M., et al.
Publicado: (2020)

Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
por: Song, In-Sung, et al.
Publicado: (2011)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Could Digital Therapeutics be a Game Changer in Psychiatry?
por: Cho, Chul-Hyun, et al.
Publicado: (2019)

Stem Cell Theory of Cancer: Rude Awakening or Bad Dream from Cancer Dormancy?
por: Tu, Shi-Ming, et al.
Publicado: (2022)

Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
por: Jagust, Petra, et al.
Publicado: (2019)

Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
por: Bano, Daniele, et al.
Publicado: (2023)

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
por: Nguyen, Khoa, et al.
Publicado: (2022)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mafstsnop5crbn2do4q51htngo